HighVista Strategies’s Celgene Corp CELG Stock Holding History

HighVista Strategies’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-36,803	Closed	-$3.65M	–	159
2019 Q3	$3.65M	Hold	36,803	–	–	2.49%	11
2019 Q2	$3.4M	Hold	36,803	–	–	1.74%	8
2019 Q1	$3.47M	Buy	+36,803	New	+$3.22M	2.83%	9

Other funds holding CELG

Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return

HCM

Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return

PCMC

Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return

WCG

Weaver Consulting Group Huntington Beach, California $488M AUM 17.59% 1-Year Est. Return

HighVista Strategies's CELG Position: Q4 2019 in Review

HighVista Strategies sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 36,803 shares — an estimated $3.65M sold.

HighVista Strategies first reported a position in CELG in Q1 2019 and held it in 3 quarters. The position peaked at $3.65M in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

HighVista Strategies reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
HighVista Strategies sold 36,803 Celgene Corp shares in Q4 2019, an estimated $3.65M.
HighVista Strategies first reported a position in Celgene Corp in Q1 2019 and held it in 3 quarters.
HighVista Strategies's Celgene Corp position peaked at $3.65M in Q3 2019.
4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on HighVista Strategies's 13F filing for Q4 2019, filed 14 Feb 2020.